Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Portfolio Pulse from Benzinga Insights
Benzinga has released its top ratings upgrades and downgrades for June 16, 2023. Notable upgrades include West Pharmaceutical Services, Abcam, AutoZone, and MorphoSys, while downgrades include Applied Materials, Truist Financial, Bausch Health Companies, RPC, NexTier Oilfield Solutions, Evotec, and SoFi Technologies.

June 16, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Materials downgraded from Buy to Neutral by New Street Research.
The downgrade from Buy to Neutral by New Street Research indicates a less positive outlook for Applied Materials, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Bausch Health Companies downgraded from Outperform to Market Perform by TD Cowen.
The downgrade from Outperform to Market Perform by TD Cowen indicates a less positive outlook for Bausch Health Companies, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Evotec downgraded from Buy to Neutral by B of A Securities.
The downgrade from Buy to Neutral by B of A Securities indicates a less positive outlook for Evotec, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
NexTier Oilfield Solutions downgraded from Buy to Neutral by Citigroup.
The downgrade from Buy to Neutral by Citigroup indicates a less positive outlook for NexTier Oilfield Solutions, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
RPC downgraded from Neutral to Sell by Citigroup.
The downgrade from Neutral to Sell by Citigroup indicates a negative outlook for RPC, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
SoFi Technologies downgraded from Buy to Neutral by B of A Securities and Piper Sandler.
The downgrade from Buy to Neutral by both B of A Securities and Piper Sandler indicates a less positive outlook for SoFi Technologies, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Truist Financial downgraded from Buy to Hold by Odeon Capital.
The downgrade from Buy to Hold by Odeon Capital indicates a less positive outlook for Truist Financial, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Abcam upgraded from Neutral to Buy by B of A Securities.
The upgrade from Neutral to Buy by B of A Securities indicates a positive outlook for Abcam, which could lead to an increase in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
AutoZone upgraded from Neutral to Buy by UBS.
The upgrade from Neutral to Buy by UBS indicates a positive outlook for AutoZone, which could lead to an increase in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
MorphoSys upgraded from Underweight to Overweight by JP Morgan.
The upgrade from Underweight to Overweight by JP Morgan indicates a positive outlook for MorphoSys, which could lead to an increase in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
West Pharmaceutical Services upgraded from Neutral to Buy by B of A Securities.
The upgrade from Neutral to Buy by B of A Securities indicates a positive outlook for West Pharmaceutical Services, which could lead to an increase in its stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100